Dimensional Fund Advisors LP Grows Holdings in CVS Health Corporation $CVS

Dimensional Fund Advisors LP increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,197,464 shares of the pharmacy operator’s stock after purchasing an additional 207,335 shares during the period. Dimensional Fund Advisors LP’s holdings in CVS Health were worth $516,796,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Parallel Advisors LLC increased its position in CVS Health by 7.5% in the 1st quarter. Parallel Advisors LLC now owns 12,478 shares of the pharmacy operator’s stock valued at $896,000 after acquiring an additional 869 shares during the period. KBC Group NV lifted its position in CVS Health by 40.5% during the 1st quarter. KBC Group NV now owns 950,953 shares of the pharmacy operator’s stock worth $68,297,000 after acquiring an additional 274,144 shares during the period. SEB Asset Management AB purchased a new position in shares of CVS Health in the 1st quarter valued at approximately $62,636,000. Swiss National Bank increased its holdings in shares of CVS Health by 7.2% in the first quarter. Swiss National Bank now owns 3,725,460 shares of the pharmacy operator’s stock valued at $267,563,000 after purchasing an additional 249,800 shares during the period. Finally, World Equity Group Inc. increased its holdings in shares of CVS Health by 27.1% in the first quarter. World Equity Group Inc. now owns 6,932 shares of the pharmacy operator’s stock valued at $498,000 after purchasing an additional 1,479 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on CVS shares. JPMorgan Chase & Co. increased their price target on CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a report on Tuesday, May 12th. Mizuho boosted their price objective on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. UBS Group upped their price objective on shares of CVS Health from $100.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft raised their target price on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, Morgan Stanley lifted their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. Twenty-one analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $105.38.

Insider Activity

In other CVS Health news, Director Larry Robbins sold 370,462 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the transaction, the director directly owned 4,824,799 shares of the company’s stock, valued at approximately $450,877,466.55. This trade represents a 7.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 3,441,551 shares of company stock valued at $323,703,977 in the last quarter. Company insiders own 0.85% of the company’s stock.

CVS Health Stock Up 0.0%

CVS Health stock opened at $107.49 on Tuesday. The stock’s 50 day moving average price is $99.28 and its 200 day moving average price is $85.36. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $108.97. The company has a market cap of $137.15 billion, a PE ratio of 47.35, a price-to-earnings-growth ratio of 1.05 and a beta of 0.61. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The firm had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. During the same quarter in the prior year, the business posted $2.25 earnings per share. CVS Health’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 7.46 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 117.18%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.